Document is current
Any future updates will be listed below
-
Authors
Pang, Yanan
Gao, Ye
Liu, Guobin
Zhao, Jingxiang
Lin, Han
Wang, Yilin
Xin, Lei
Wang, Wei
Bian, Yan
Jiao, Yunfei
Li, Qiuxin
Li, Zengjun https://orcid.org/0000-0003-0787-8089
Li, Zhaoshen https://orcid.org/0000-0002-6294-7721
Huang, He https://orcid.org/0000-0001-6998-8131
Wang, Luowei https://orcid.org/0000-0002-6647-786X
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82403564)
National Natural Science Foundation of China (22277125 and 92253306)
National Natural Science Foundation of China (82370677)
Strategic Priority Research Program of the Chinese Academy of Sciences (XDB1060000)
Natural Science Foundation of Shanghai (23ZR1474600)
Science and Technology Commission of Shanghai Municipality (21Y31900100 and 21Y31900101)
- License Information
-
More Information
Article History
Received: 1 May 2026
Accepted: 21 July 2026
First Online: 28 July 2026
Declarations
Ethics approval and consent to participate: This study was approved by the Ethics Committee of Changhai Hospital (Shanghai, China, approval number 2022–225 for the proteogenomic cohort; 2024–038 for the CMECC cohort). Informed consent was obtained from all the participants. This study was performed in accordance with the Declaration of.Helsinki. Patients or the public WERE NOT involved in the design, or conduct, or reporting, or dissemination plans of our research. The animal experiments were approved by the ethics committee and performed at the animal experiment center of Changhai Hospital (approval number: 2024–054).
Consent for publication: Not applicable.
Competing interests: The authors declare that they have no competing interests.
